Cargando…
Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis
BACKGROUND: Accumulating evidence has demonstrated that aberrant expression of deubiquitinating enzymes is associated with the initiation and progression of Triple-negative breast cancer (TNBC). The publicly available TCGA database of breast cancer data was used to analyze the OTUD deubiquitinating...
Autores principales: | Han, Zhitao, Jia, Qi, Zhang, Jing, Chen, Miaomiao, Wang, Lining, Tong, Kai, He, Weiwei, Zhang, Yajie, Zhu, Weina, Qin, Ju, Wang, Tao, Liu, Tielong, Ma, Yong, Chen, Yuanming, Zha, Siluo, Zhang, Chunlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478497/ https://www.ncbi.nlm.nih.gov/pubmed/37667382 http://dx.doi.org/10.1186/s13046-023-02781-3 |
Ejemplares similares
-
The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
por: Du, Tongde, et al.
Publicado: (2019) -
YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022) -
Deubiquitylation of deubiquitylases
por: Haq, Saba, et al.
Publicado: (2017) -
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017) -
Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway
por: Park, Sang-Soo, et al.
Publicado: (2023)